Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Gynecologic Neoplasms 09. June 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 16489  Previews Next
   
   Articles 1 - 20 / 329777  
   
Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan.
Breast Cancer (Dove Med Press)
Chen YC, Cheng MC, Chen PH, Chung CH, Chien WC, Dai MS, Chen JH, Huang TC.
PMID: 42261320 [PubMed]


Beyond Target Occupancy in Triple-Negative Breast Cancer: A Medicinal Chemistry Perspective on Modality-Guided Design for Durable Network Control.
J Med Chem
Zeng W, Chen Y, Neamati N, Jin Y.
PMID: 42261123 [PubMed - as supplied by publisher]


Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancer.
Exp Hematol Oncol
Sahin TK, Orhan C, Ozercan IH, Muglu H, Er B, Akyildiz A, Tunbekici S, Oruc A, Aykan MB, Koylu B, Akdogan O, Onur ID, Ates O, Yazici O, Selcukbiricik F, Karadurmus N, Araz M, Erdem D, Goker E, Bilici A, Aksoy S, Guven DC.
PMID: 42260640 [PubMed]


Meta-analysis reveals pathological complete response benefits from neoadjuvant immuno-chemotherapy combination in patients with HER2-negative breast cancer.
BMC Cancer
Wei Y, Qi Y, Ge H, Zeng C, Li Q, Ma F.
PMID: 42260448 [PubMed - as supplied by publisher]


Constructing a prognostic survival model for patients with stage II-IV epithelial ovarian cancer: a study based on the SEER database and external validation in China.
Sci Rep
Ying L, Zhang Z, Sun X, Wang X, Zhou Y, Zhao L.
PMID: 42260148 [PubMed - as supplied by publisher]


A PML1-CCL5-PI3K/MAPK feedback loop governs survival of endocrine-resistant breast cancer cells.
Cell Death Differ
Wang H, Yun Z, Cao Y, Li X, Liu Z, Pai CP, Wu C, Yue J, Lin G, Cai J, Fang S, Li K, Willard B, Yang S, Keri RA, Schiemann WP, Diehl JA, Kao HY.
PMID: 42260104 [PubMed - as supplied by publisher]


First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial.
Nat Cancer
Schmid P, Im SA, Nowecki Z, Wysocki PJ, Jassem J, Jung KH, Lord S, Armstrong J, Stewart R, Vukovi, Denduluri N, Park YH.
PMID: 42259988 [PubMed - as supplied by publisher]


International consensus on axillary staging after neoadjuvant chemotherapy in node-positive breast cancer.
Eur J Surg Oncol
Lucocq J, Karakatsanis A, Kirwan C, Boughey J, Tseng J, Sun SX, Gentilini OD, Barber M, Chagla L, Buccimazza I, Dick L, Massannat Y, Dixon JM, Kühn T, Benson J, Elder K, NAC-AX Collaborative Group.
PMID: 42259722 [PubMed - as supplied by publisher]


Combined targeting of mesothelin and tenascin-C enhances CAR-T cell function and tumor microenvironment modulation in ovarian cancer.
Mol Immunol
Wang X, Zhang D, Wang T, Li X, Zhang J.
PMID: 42259008 [PubMed - as supplied by publisher]


Psychometric evaluation of the NFOSI-18 disease related symptoms - Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004.
Gynecol Oncol
Tang X, Huang H, Peipert JD, Zola A, Buscema J, Yang K, Tew W, O'Cearbhaill RE, Muller C, Goodheart MJ, Moore RG, Liu R, Geller MA, Michener C, Chan J, Carney M, McNally L, Street D, Bookman MA, Moore KN, Liu JF, Wenzel L, Cella D.
PMID: 42258989 [PubMed - as supplied by publisher]


Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer.
ESMO Open
Salehi E, Chu X, Mayer EL, Singer S, Augdahl G, Stalteri M, Li T, Dibble KE, Sinclair N, Faggen M, Walsh J, Sammons S, Sendrick K, Hanna S, Mostaghimi A, Tayob N, LeBoeuf NR, Tolaney SM.
PMID: 42258966 [PubMed - as supplied by publisher]


Comparison of long-term survival between primary and interval cytoreductive surgery in advanced ovarian cancer: A ten-year real-world cohort study.
Eur J Surg Oncol
Duan X, Tan S, Wang C, Liu J, Huang L, Zhang Y.
PMID: 42258952 [PubMed - as supplied by publisher]


Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation Studies.
J Clin Oncol
Braunstein LZ, Mitchell MP, Khan AJ, Sikov WM, Mamounas EP, Julian TB, Wolmark N.
PMID: 42258793 [PubMed - as supplied by publisher]


The use of menopause hormone therapy in borderline ovarian tumor survivors: a systematic review and meta-analysis.
Climacteric
Mejia-Gomez J, Tigert M, Jacobson M, Shprits E, Shea AK, Philippopoulos E, Kotsopoulos J, Bridger A, Sanchez Diaz N, Puveendrakumaran P, Shaltout N, Benipal H, Sosea C, Leslie B, Garzon A, Wolfman W, Zigras T.
PMID: 42258345 [PubMed - as supplied by publisher]


SAFE-IOERT prospective study: clinical outcomes of exclusive intraoperative radiotherapy in early breast cancer according to molecular subtype and tumor-infiltrating lymphocytes.
Clin Transl Oncol
Oses G, Clavell C, González-Farré B, Sanfeliu E, Laplana M, Martínez A, Moreno S, Meca G, Gomis E, Carreras-Ballvé J, Mension E, Cebrecos I, Caparrós X, Tarrats-Rosell J, Cases C, Herreros A, Mollŕ M.
PMID: 42258139 [PubMed - as supplied by publisher]


Withaferin A in breast cancer therapy: multi-targeted modulation of redox homeostasis, autophagy, and apoptosis.
J Asian Nat Prod Res
Patel N, Gupta A, Mishra R, Pandey SN, Goyal K, Ali H, Maji C, Rekha A, Hussain MS, Singh SK, Gupta G.
PMID: 42257714 [PubMed - as supplied by publisher]


Dynamic breast magnetic resonance imaging features and pathological correlation of patients diagnosed with breast cancer under the age of 40.
Acta Radiol
Gundogdu V, Meltem E, Ulusan MB, Bozkurt H, Mahmutoglu AS.
PMID: 42257534 [PubMed - as supplied by publisher]


Ipsilateral Breast Tumor Detected 20 Years after Occult Breast Cancer: A Diagnostic Challenge in Distinguishing New Primary Cancer from Late Recurrence.
Case Rep Oncol
Masuda Y, Tanaka M, Koga Y, Eto K, Watanabe R, Yoshinaga Y, Satou T.
PMID: 42257037 [PubMed]


Non-pharmacological sleep management in breast cancer survivors: Evidence from a systematic review and meta-analysis of RCTs.
Prev Med Rep
Aemmi SZ, Mohammadi-Pirouz Z, Moradi M.
PMID: 42256805 [PubMed]


Financial incentives for women's cervical, breast and colorectal cancer screening adherence: systematic review and meta-analysis.
Prev Med Rep
Lumia C, Nespoli A, Ausili D, Fumagalli S, Dumont A.
PMID: 42256798 [PubMed]


   
   Articles 1 - 20 / 329777    Page 1 of 16489  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1